Sign In
Buy AAIGF
AIA Group Earnings Calls
| Release date | Aug 20, 2025 |
| EPS estimate | $0.290 |
| EPS actual | $1.86 |
| EPS Surprise | 541.38% |
| Revenue estimate | - |
| Revenue actual | 15.448B |
| Release date | May 22, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Release date | Apr 30, 2025 |
| EPS estimate | $0.360 |
| EPS actual | $0.323 |
| EPS Surprise | -10.39% |
| Revenue estimate | - |
| Revenue actual | 12.174B |
| Release date | Dec 11, 2024 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for AIA Group
Below you can see how AAIGF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Dec 11, 2024 |
| Price on release | $7.79 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Dec 05, 2024 | $7.18 |
| Dec 06, 2024 | $7.14 |
| Dec 09, 2024 | $7.61 |
| Dec 10, 2024 | $7.51 |
| Dec 11, 2024 | $7.79 |
| Dec 12, 2024 | $7.25 |
| Dec 13, 2024 | $7.10 |
| Dec 16, 2024 | $6.90 |
| Dec 17, 2024 | $7.05 |
| 4 days before | 8.50% |
| 4 days after | -9.50% |
| On release day | -6.93% |
| Change in period | -1.81% |
| Release date | Apr 30, 2025 |
| Price on release | $7.34 |
| EPS estimate | $0.360 |
| EPS actual | $0.323 |
| EPS surprise | -10.39% |
| Date | Price |
|---|---|
| Apr 24, 2025 | $7.09 |
| Apr 25, 2025 | $7.43 |
| Apr 28, 2025 | $6.96 |
| Apr 29, 2025 | $6.86 |
| Apr 30, 2025 | $7.34 |
| May 01, 2025 | $7.51 |
| May 02, 2025 | $7.90 |
| May 05, 2025 | $7.87 |
| May 06, 2025 | $7.71 |
| 4 days before | 3.53% |
| 4 days after | 5.04% |
| On release day | 0% |
| Change in period | 8.74% |
| Release date | May 22, 2025 |
| Price on release | $8.56 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| May 16, 2025 | $8.44 |
| May 19, 2025 | $8.29 |
| May 20, 2025 | $8.18 |
| May 21, 2025 | $8.56 |
| May 22, 2025 | $8.56 |
| May 23, 2025 | $8.56 |
| May 27, 2025 | $8.20 |
| May 28, 2025 | $8.30 |
| May 29, 2025 | $8.25 |
| 4 days before | 1.42% |
| 4 days after | -3.62% |
| On release day | 0% |
| Change in period | -2.25% |
| Release date | Aug 20, 2025 |
| Price on release | $9.20 |
| EPS estimate | $0.290 |
| EPS actual | $1.86 |
| EPS surprise | 541.38% |
| Date | Price |
|---|---|
| Aug 14, 2025 | $9.71 |
| Aug 15, 2025 | $9.69 |
| Aug 18, 2025 | $9.84 |
| Aug 19, 2025 | $9.37 |
| Aug 20, 2025 | $9.20 |
| Aug 21, 2025 | $9.73 |
| Aug 22, 2025 | $9.71 |
| Aug 25, 2025 | $9.50 |
| Aug 26, 2025 | $9.46 |
| 4 days before | -5.25% |
| 4 days after | 2.81% |
| On release day | 5.76% |
| Change in period | -2.59% |
AIA Group Earnings Call Transcript Summary of Q2 2025
AIA reported an excellent first half of 2025 with double-digit growth across key metrics: VONB rose 14% to a record $2.8bn, OPAT and UFSG per share each grew (OPAT up 12% per share; UFSG per share up 10%), and operating ROEV and ROE reached record highs (17.8% and 16.2% respectively). The Board declared a 10% increase in the interim dividend and the group returned $3.7bn to shareholders (dividends + buybacks) in H1; the shareholder capital ratio stood at 219%. Regionally, Hong Kong delivered a record VONB ($1.1bn, +24%) driven by a #1 Premier Agency and strong partnership performance; China VONB accelerated (H1 $743m, stronger in Q2) with a differentiated Premier Agency and a stated ambition for new regions to grow at ~40% CAGR over five years; ASEAN and India also delivered strong, protection-led growth (ASEAN VONB +20%, Tata AIA VONB +38%). Product mix remains heavily protection and long-term savings (roughly 85–90% VONB from protection/fee-based products) which supports predictable cash flow and low interest-rate sensitivity. Management highlighted technological and health offerings (AI-driven Amplify Health, generative AI, integrated healthcare) as competitive advantages. Capital policy remains disciplined: a target payout ratio of ~75% of net free surplus generation and flexibility to return excess capital via buybacks, while prioritizing high-return organic reinvestment.
